(2E,6E)-8-Hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate

Catalog No. :
ACQJYC745
CAS No. :
37905-03-6
Molecular Formula :
C12H20O3
Molecular Weight :
212.29

IUPAC Name:(2E,6E)-8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate

(2E,6E)-8-Hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$1192.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2E,6E)-8-Hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate
IUPAC Name(2E,6E)-8-hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate
MDL No.MFCD31391065
Molecular FormulaC12H20O3
Molecular Weight212.29
SMILESOC/C(C)=C/CC/C(C)=C/COC(C)=O
InChI KeyHZIJXISIZGWHAY-NXAIOARDSA-N
Synonym8-hydroxygeranyl acetate;(E,E)-8-acetoxy-2,6-dimethyl-2,6-octadien-1-ol;2,6-Octadiene-1,8-diol, 2,6-dimethyl-, 8-acetate, (2E,6E)-;1H-Isoindole-1,3(2H)-dione,2-[2-(3,4-dihydro-2,2,4-trimethyl-1(2H)-quinolinyl)-7-oxoethyl]-;(2E,6E)-8-Hydroxy-3,7-dimethylocta-2,6-dien-1-yl acetate
CAS No.37905-03-6
PubChem CID10375891

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACQJYC745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRPSD019 route compound structure diagram
    ACRPSD019105-87-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQJYC745 route product structure diagram
    ACQJYC74537905-03-6
Inquiry

2. ACQJYC745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  4. Then
  5. ACQJYC745 route product structure diagram
    ACQJYC74537905-03-6
Inquiry

Comments (0)